ALERT

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Buprenorphine/Naloxone (Bup/Nx) Facilitated Rehabilitation for Heroin Addicted Adolescents/Young Adults

The usual treatment for opioid-addicted youth is detoxification and counseling. Some treatment providers are reluctant to use opioid agonist medications in this population, especially for long-term opioid maintenance. This study compared Bup/Nx treatment for 9 weeks and taper for 3 weeks to treatment as usual (Bup/Nx detox for 2 weeks). Both arms received counseling for 12 weeks.

CTN Protocol ID:

CTN-0010

DSMB ID:

DSMB-0010

Status:

Completed

ClinicalTrials.gov ID:

NCT00078130

Principal Investigator(s)

George E. Woody, M.D.

Professor

University of Pennsylvania School of Medicine

Treatment Research Institute

Department of Psychiatry

600 Public Ledger Building
150 S. Independence Mall - West
Philadelphia, PA 19106
United States

woody@tresearch.org

Participating Sites

Mountain Manor Treatment Programs, Maryland
Mercy Hospital, Maine
Addiction & Substance Abuse Programs (ASAP), New Mexico